Krka d. d (WAR:KRK) — Market Cap & Net Worth
Market Cap & Net Worth: Krka d. d (KRK)
Krka d. d (WAR:KRK) has a market capitalization of $8.59 Billion (zł31.21 Billion) as of May 3, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #2497 globally and #11 in its home market, demonstrating a -0.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Krka d. d's stock price zł1022.00 by its total outstanding shares 30540879 (30.54 Million). Analyse KRK cash flow conversion to see how efficiently the company converts income to cash.
Krka d. d Market Cap History: 2015 to 2026
Krka d. d's market capitalization history from 2015 to 2026. Data shows growth from $1.50 Billion to $8.59 Billion (18.64% CAGR).
Krka d. d Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Krka d. d's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.58x
Krka d. d's market cap is 2.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.80x
Krka d. d's market cap is 13.80 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.50 Billion | $1.16 Billion | $158.25 Million | 1.29x | 9.47x |
| 2016 | $1.38 Billion | $1.17 Billion | $108.45 Million | 1.17x | 12.71x |
| 2017 | $1.37 Billion | $1.27 Billion | $152.60 Million | 1.08x | 8.95x |
| 2018 | $1.51 Billion | $1.33 Billion | $174.59 Million | 1.14x | 8.67x |
| 2019 | $1.99 Billion | $1.49 Billion | $245.54 Million | 1.33x | 8.12x |
| 2020 | $2.92 Billion | $1.53 Billion | $291.00 Million | 1.90x | 10.03x |
| 2021 | $3.92 Billion | $1.57 Billion | $309.21 Million | 2.50x | 12.67x |
| 2022 | $3.28 Billion | $1.72 Billion | $363.30 Million | 1.91x | 9.04x |
| 2023 | $3.86 Billion | $1.81 Billion | $313.95 Million | 2.14x | 12.29x |
| 2024 | $4.93 Billion | $1.91 Billion | $356.99 Million | 2.58x | 13.80x |
Competitor Companies of KRK by Market Capitalization
Companies near Krka d. d in the global market cap rankings as of May 3, 2026.
Key companies related to Krka d. d by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Krka d. d Historical Marketcap From 2015 to 2026
Between 2015 and today, Krka d. d's market cap moved from $1.50 Billion to $ 8.59 Billion, with a yearly change of 18.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł8.59 Billion | +18.84% |
| 2025 | zł7.23 Billion | +46.76% |
| 2024 | zł4.93 Billion | +27.63% |
| 2023 | zł3.86 Billion | +17.54% |
| 2022 | zł3.28 Billion | -16.20% |
| 2021 | zł3.92 Billion | +34.28% |
| 2020 | zł2.92 Billion | +46.35% |
| 2019 | zł1.99 Billion | +31.68% |
| 2018 | zł1.51 Billion | +10.85% |
| 2017 | zł1.37 Billion | -0.94% |
| 2016 | zł1.38 Billion | -7.96% |
| 2015 | zł1.50 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Krka d. d was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.59 Billion USD |
| MoneyControl | $8.59 Billion USD |
| MarketWatch | $8.59 Billion USD |
| marketcap.company | $8.59 Billion USD |
| Reuters | $8.59 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolis… Read more